Comparing the Effectiveness of Khadir Vati and Atorvastatin in Managing High Cholesterol: A Clinical Trial

Evaluation of Comparative Efficacy of Khadir Vati Versus Atorvastatin in the Management of Dyslipidemia - A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093594

Enrollment

Registered

2025-08-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to Participate with written informed consent Patient between age group 30 to 60 years of either sex Newly diagnosed cases of Dyslipidemia according to National Cholesterol Education Program and Adult Treatment Panel III (NCEP ATP III 2004) as follows TCH more than or equal to 200 mg per dL and or LDL C between 130 to 189 mg per dL and or Serum TG between 150 to 499 mg per dL and or Serum HDL C less than 40mg per Dl

Exclusion criteria

Exclusion criteria: Known cases of major illness like cardiovascular disorder, hepatic, & renal disorders Dyslipidemia due to consumption of drug such as glucocorticoids Subjects having MI (myocardial infarction), Angina, Stroke, TIA (transient ischemic attack), major cardiovascular surgeries in 6 months Patients already on statins or other lipid-lowering agents and blood thinner Pregnant and Lactating women

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Khadir Vati and Atorvastatin on Lipid Levels ? Total cholesterol, Triglyceride, LDL (Low density lipoprotein) and HDL (High density lipoprotein). Timepoint: at baseline 45 day	—

Secondary

Measure	Time frame
comparison & assessment of efficacy of Khadir Vati & Atorvastatin on Lipid Levels ? Total cholesterol, Triglyceride, LDL (Low density lipoprotein) & HDL (High density lipoprotein)Timepoint: at baseline 6 weeks 3 days	—

Countries

India

Contacts

Public ContactDr Shital Gulabrao Chavan

Mahtma Gandhi Ayurved College Hospital and Research Centre salod hirapur wardha

wajpayeisadhana@gmail.com9763732083

Outcome results